mp-MRI prostate characterised PIRADS 3 lesions are associated with a low risk of clinically significant prostate cancer - a retrospective review of 92 biopsied PIRADS 3 Lesions

被引:0
|
作者
Liddell, H. [1 ]
Jyoti, R. [2 ]
Haxhimolla, H. Z. [1 ,3 ]
机构
[1] Canberra Hosp, Dept Urol, Garran, Australia
[2] Calvary Hosp, Universal Med Imaging, Bruce, Australia
[3] Australian Natl Univ, Acton, Australia
关键词
D O I
暂无
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
201
引用
收藏
页码:95 / 96
页数:2
相关论文
共 50 条
  • [31] Retrospective analysis of the development of PIRADS 3 lesions over time: when is a follow-up MRI reasonable?
    Fabian Steinkohl
    Leonhard Gruber
    Jasmin Bektic
    Udo Nagele
    Friedrich Aigner
    Thomas R. W. Herrmann
    Michael Rieger
    Daniel Junker
    World Journal of Urology, 2018, 36 : 367 - 373
  • [32] Predictors of Clinically Significant Prostate Cancer in Patients with PIRADS Categories 3-5 Undergoing Magnetic Resonance Imaging-Ultrasound Fusion Biopsy of the Prostate
    Szemplinski, Stanislaw
    Kamecki, Hubert
    Debowska, Malgorzata
    Zagozdzon, Bartlomiej
    Mokrzys, Mateusz
    Zawadzki, Marek
    Sosnowski, Roman
    Tokarczyk, Andrzej
    Poletajew, Slawomir
    Kryst, Piotr
    Nyk, Lukasz
    JOURNAL OF CLINICAL MEDICINE, 2023, 12 (01)
  • [33] Comparison of PIRADS 3 lesions with histopathological findings after MRI-fusion targeted biopsy of the prostate in a real world-setting
    Schlenker, B.
    Apfelbeck, M.
    Armbruster, M.
    Chaloupka, M.
    Stief, C. G.
    Clevert, D-A
    CLINICAL HEMORHEOLOGY AND MICROCIRCULATION, 2019, 71 (02) : 165 - 170
  • [34] Retrospective analysis of the development of PIRADS 3 lesions over time: when is a follow-up MRI reasonable?
    Steinkohl, Fabian
    Gruber, Leonhard
    Bektic, Jasmin
    Nagele, Udo
    Aigner, Friedrich
    Herrmann, Thomas R. W.
    Rieger, Michael
    Junker, Daniel
    WORLD JOURNAL OF UROLOGY, 2018, 36 (03) : 367 - 373
  • [35] DOES 4K AND/OR MICHIGAN PROSTATE SCORE CHANGE CANCER DETECTION RATES IN MULTI-PARAMETRIC MRI DISCOVERED PIRADS 3 OR LOWER LESIONS?
    Tan, Wei Phin
    Whelan, Patrick
    Phelps, Jessica
    Strong, Andrea
    Lowe, Megan
    Shors, Stephanie
    White, Gregory
    Ekbal, Shahid
    McKiel, Charles
    Deane, Leslie
    JOURNAL OF UROLOGY, 2017, 197 (04): : E1269 - E1269
  • [36] The role of multiparametric MRI apparent diffusion co-efficient (ADC) values in prostate cancer grading and staging in men with PIRADS 3-5 mpMRI lesions
    Raveenthiran, S.
    Yaxley, J.
    Brown, N.
    Parkinson, R.
    Samaratunga, H.
    BJU INTERNATIONAL, 2019, 123 : 81 - 82
  • [37] Clinical -Prostate cancer Multicenter analysis of clinical and MRI characteristics associated with detecting clinically significant prostate cancer in PI-RADS (v2.0) category 3 lesions
    Al Awamlh, Bashir Al Hussein
    Marks, Leonard S.
    Sonn, Geoffrey A.
    Natarajan, Shyam
    Fan, Richard E.
    Gross, Michael D.
    Mauer, Elizabeth
    Banerjee, Samprit
    Hectors, Stefanie
    Carlsson, Sigrid
    Margolis, Daniel J.
    Hu, Jim C.
    UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS, 2020, 38 (07)
  • [38] Detecting clinically significant prostate cancer with multiparametric MRI using prostate imaging reporting and data system version 2 (PIRADS v2) - A real life application
    Aslim, Edwin Jonathan
    Lee, Lui Shiong
    Khor, Li Yan
    Aydin, Hakan
    Tan, Puay Hoon
    Chidambaram, Viswanath Anand
    Cheng, Lionel
    Law, Yan Mee
    Carson, John Allen
    INTERNATIONAL JOURNAL OF UROLOGY, 2016, 23 : 79 - 79
  • [39] Biparametric MRI-based radiomics for prediction of clinically significant prostate cancer of PI-RADS category 3 lesions
    Lu, Feng
    Zhao, Yanjun
    Wang, Zhongjuan
    Feng, Ninghan
    BMC CANCER, 2025, 25 (01)
  • [40] Automated Detection of Clinically Significant Prostate Cancer in mp-MRI Images Based on an End-to-End Deep Neural Network
    Wang, Zhiwei
    Liu, Chaoyue
    Cheng, Danpeng
    Wang, Liang
    Yang, Xin
    Cheng, Kwang-Ting
    IEEE TRANSACTIONS ON MEDICAL IMAGING, 2018, 37 (05) : 1127 - 1139